Company profile page for Jaguar Health Inc including stock price, company news, press releases, executives, board members, and contact information There is not enough analysis data for Jaguar Health. Help Center . Thinking about buying stock in Polarityte, Jaguar Health, SRAX, ReneSola, or Marathon Patent Group? Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Jaguar Health Inc. NASDAQ Updated Mar 16, 2021 11:59 PM JAGX 2.10 0.15 (6.67%). Jaguar Health (JAGX) stock is on the rise Thursday after announcing a meeting concerning an upcoming SPAC merger in Italy. (Add your “outperform” vote. From MarketWatch news today: Jaguar Health Inc. “Another frequently discussed penny stock is Jaguar Health Inc. For some context, this is a commercial-stage pharmaceutical company developing non-opioid-based treatments. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. A terrifying (for some) and new disruptive force is creating thousands of new millionaires (Barron’s reports 20,000 to 200,000 so far) while at the same time destroying the financial future for many others. Identify stocks that meet your criteria using seven unique stock screeners. Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more. JAGX Stock: What to Know as SPAC News Sends Jaguar Health Soaring JAGX stock is on the move today after the popular company announced it had signed a memorandum of understanding for a SPAC deal. Jaguar Health is scheduled to release its next quarterly earnings announcement on Thursday, April 1st 2021. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Jaguar Health had a negative trailing twelve-month return on equity of 659.73% and a negative net margin of 372.81%. Fundamental company data provided by Zacks Investment Research. Based on aggregate information from My MarketBeat watchlists, some companies that other Jaguar Health investors own include Biocept (BIOC), Sorrento Therapeutics (SRNE), Trevena (TRVN), Vaxart (VXRT), Purple Biotech (KTOV), Onconova Therapeutics (ONTX), Tonix Pharmaceuticals (TNXP), Biopharmx (BPMX), Cara Therapeutics (CARA) and Conatus Pharmaceuticals (CNAT). Only 1.42% of the stock of Jaguar Health is held by institutions. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. The stock price of Jaguar Health Inc (NASDAQ: JAGX) — a commercial-stage pharmaceuticals company focused on developing plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress — increased … Our Accessibility Statement Jaguar Health Inc. (NASDAQ:JAGX) went up by 3.69% from its latest closing price compared to the recent 1-year high of $4.47. Sign-up to receive the latest news and ratings for JAGX and its competitors with MarketBeat's FREE daily newsletter. You may vote once every thirty days. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Shares of JAGX can be purchased through any online brokerage account.